726 related articles for article (PubMed ID: 24722973)
1. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
[TBL] [Abstract][Full Text] [Related]
2. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
Haas S; Ten Cate H; Accetta G; Angchaisuksiri P; Bassand JP; Camm AJ; Corbalan R; Darius H; Fitzmaurice DA; Goldhaber SZ; Goto S; Jacobson B; Kayani G; Mantovani LG; Misselwitz F; Pieper K; Schellong SM; Stepinska J; Turpie AG; van Eickels M; Kakkar AK;
PLoS One; 2016; 11(10):e0164076. PubMed ID: 27792741
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists.
Abumuaileq RR; Abu-Assi E; Raposeiras-Roubin S; López-López A; Redondo-Diéguez A; Álvarez-Iglesias D; Rodríguez-Mañero M; Peña-Gil C; González-Juanatey JR
Europace; 2015 May; 17(5):711-7. PubMed ID: 25662984
[TBL] [Abstract][Full Text] [Related]
4. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
[TBL] [Abstract][Full Text] [Related]
5. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Marin F; Gálvez J; Valdés M; Vicente V; Lip GYH
Am J Med; 2014 Nov; 127(11):1083-1088. PubMed ID: 24858062
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment.
Gorzelak-Pabiś P; Zyzak S; Krewko Ł; Broncel M
Pol Arch Med Wewn; 2016 Aug; 126(7-8):494-501. PubMed ID: 27511466
[TBL] [Abstract][Full Text] [Related]
7. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
8. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Marín F; Lip GYH
Clin Ther; 2018 Jan; 40(1):114-122. PubMed ID: 29275065
[TBL] [Abstract][Full Text] [Related]
9. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
10. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
Vanerio G
J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
[TBL] [Abstract][Full Text] [Related]
11. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
Gallego P; Roldan V; Marín F; Romera M; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 Dec; 110(6):1189-98. PubMed ID: 24096615
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.
Apostolakis S; Sullivan RM; Olshansky B; Lip GYH
Chest; 2013 Nov; 144(5):1555-1563. PubMed ID: 23669885
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
14. Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials.
Proietti M; Lane DA; Lip GY
Int J Cardiol; 2016 Aug; 216():168-72. PubMed ID: 27156060
[TBL] [Abstract][Full Text] [Related]
15. Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project.
Angoulvant D; Villejoubert O; Bejan-Angoulvant T; Ivanes F; Saint Etienne C; Lip GYH; Fauchier L
Chest; 2015 Aug; 148(2):491-498. PubMed ID: 25812113
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina.
Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M;
Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
Van Der Meersch H; De Bacquer D; De Vriese AS
Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.
Szymanski FM; Lip GY; Filipiak KJ; Platek AE; Karpinski G
Int J Cardiol; 2016 Feb; 204():200-5. PubMed ID: 26670173
[TBL] [Abstract][Full Text] [Related]
19. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
[TBL] [Abstract][Full Text] [Related]
20. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists.
Ruiz-Ortiz M; Bertomeu V; Cequier Á; Marín F; Anguita M
Thromb Haemost; 2015 Oct; 114(4):695-701. PubMed ID: 26054407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]